# Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

> **NCT05030415** · EARLY_PHASE1 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 9 (actual)

## Conditions studied

- Lichen Planus Scalp
- Lichen Planus
- Lichen Planopilaris

## Interventions

- **DRUG:** Ixekizumab Auto-Injector

## Key facts

- **NCT ID:** NCT05030415
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-12
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-03-25
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030415, "Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05030415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*